Lesson from the Hyperglycemia and Adverse Pregnancy Outcome Study: New Diagnostic Criteria for Gestational Diabetes Mellitus

Eran Hadar*, Moshe Hod, Boyd E. Metzger

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations

Abstract

The evolution of gestational diabetes mellitus (GDM) diagnosis starts at the 1960s. Since then it has been the focus of ongoing debate, regarding questions such as - when, how and who to screen? What is the most appropriate diagnostic procedure? What cutoffs to diagnose GDM? By far, the hyperglycemia and adverse pregnancy outcome (HAPO) study provided the best evidence base to support answers to some of these questions - yet, some remain unsolved and others are still a matter of debate. Translating clinical evidence to practice guidelines is not a pure matter of science, but other considerations come into play, especially when the associations between the diagnostic variables to the selected outcomes are linear. Here, we shall provide an overview of the pathway which has led to HAPO and the path taken since its publication, striding toward a consensus for GDM diagnosis.

Original languageEnglish (US)
Title of host publicationFrontiers in Diabetes
PublisherS. Karger AG
Pages35-49
Number of pages15
DOIs
StatePublished - 2019

Publication series

NameFrontiers in Diabetes
Volume28
ISSN (Print)0251-5342
ISSN (Electronic)1662-2995

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint

Dive into the research topics of 'Lesson from the Hyperglycemia and Adverse Pregnancy Outcome Study: New Diagnostic Criteria for Gestational Diabetes Mellitus'. Together they form a unique fingerprint.

Cite this